Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Digestion
|
August 18, 2015
Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC Trial
Thomas Greuter, Silvia Lang, Ernst Holler, et al.
Gastroenterology
|
October 3, 2002
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis
Loren Laine, Claire Bombardier, Christopher J Hawkey, et al.
The American Journal of the Medical Sciences
|
October 28, 2011
Rofecoxib and clinically significant gastrointestinal events
Claire Bombardier, Loren Laine, Richard Day, et al.
Inflammatory Bowel Diseases
|
February 21, 2002
Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease
Maeve M Skelly, Richard F A Logan, David Jenkins, et al.
Inflammatory Bowel Diseases
|
May 4, 2012
Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease
Venkataraman Subramanian, Vidyasagar Ramappa, Emmanouil Telakis, et al.
Arthritis Research & Therapy
|
March 30, 2007
Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies
Christopher J Hawkey, Nicholas J Talley, James M Scheiman, et al.
World Journal of Gastroenterology
|
December 26, 2008
Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells
Johannes Beltinger, Jo del Buono, Maeve M Skelly, et al.
Gastroenterology
|
January 31, 2003
Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use
Loren Laine, Laurine G Connors, Alise Reicin, et al.
Gastroenterology
|
July 17, 2007
Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study
Christopher J Hawkey, Wilfred M Weinstein, Walter Smalley, et al.
The Lancet. Gastroenterology & Hepatology
|
May 13, 2017
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial
James O Lindsay, Mathieu Allez, Miranda Clark, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Digestion
|
August 18, 2015
Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC Trial
Thomas Greuter, Silvia Lang, Ernst Holler, et al.
Gastroenterology
|
October 3, 2002
Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis
Loren Laine, Claire Bombardier, Christopher J Hawkey, et al.
The American Journal of the Medical Sciences
|
October 28, 2011
Rofecoxib and clinically significant gastrointestinal events
Claire Bombardier, Loren Laine, Richard Day, et al.
Inflammatory Bowel Diseases
|
February 21, 2002
Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease
Maeve M Skelly, Richard F A Logan, David Jenkins, et al.
Inflammatory Bowel Diseases
|
May 4, 2012
Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease
Venkataraman Subramanian, Vidyasagar Ramappa, Emmanouil Telakis, et al.
Arthritis Research & Therapy
|
March 30, 2007
Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies
Christopher J Hawkey, Nicholas J Talley, James M Scheiman, et al.
World Journal of Gastroenterology
|
December 26, 2008
Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells
Johannes Beltinger, Jo del Buono, Maeve M Skelly, et al.
Gastroenterology
|
January 31, 2003
Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use
Loren Laine, Laurine G Connors, Alise Reicin, et al.
Gastroenterology
|
July 17, 2007
Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study
Christopher J Hawkey, Wilfred M Weinstein, Walter Smalley, et al.
The Lancet. Gastroenterology & Hepatology
|
May 13, 2017
Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial
James O Lindsay, Mathieu Allez, Miranda Clark, et al.
Page
of 5